Algert Global LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Algert Global LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$144.95 - $152.29 $775,337 - $814,599	5,349 Added 38.64%	19,192 $2.9 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $115,564 - $202,926	1,390 Added 11.16%	13,843 $2.02 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $1.07 Million - $1.39 Million	9,734 Added 358.0%	12,453 $1.48 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $152,586 - $227,174	-1,530 Reduced 36.01%	2,719 $375,000
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $420,013 - $590,228	4,249 New	4,249 $590,000
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $697,466 - $998,790	-10,886 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $708,352 - $1.07 Million	10,886 New	10,886 $933,000
Q2 2020 Aug 12, 2020	SELL	$29.01 - $74.23 $211,860 - $542,101	-7,303 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$27.51 - $57.29 $200,905 - $418,388	7,303 New	7,303 $249,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.